Show simple item record

dc.contributor.authorSinha, Bhaswati
dc.contributor.authorCao, Zhengyu
dc.contributor.authorMurray, Thomas F.
dc.contributor.authorAldrich, Jane V.
dc.date.accessioned2017-04-06T16:45:34Z
dc.date.available2017-04-06T16:45:34Z
dc.date.issued2009-12-10
dc.identifier.citationSinha, B., Cao, Z., Murray, T. F., & Aldrich, J. V. (2009). Discovery of Dermorphin-Based Affinity Labels with Subnanomolar Affinity for Mu Opioid Receptors. Journal of Medicinal Chemistry, 52(23), 7372–7375. http://doi.org/10.1021/jm9007592en_US
dc.identifier.urihttp://hdl.handle.net/1808/23589
dc.description.abstractA series of potent electrophilic affinity labels (IC50 = 0.1-5 nM) containing either a bromoacetamide or isothiocyanate based on the mu opioid receptor (MOR) selective peptide dermorphin were prepared. All four analogs exhibited wash resistant inhibition of [3H]DAMGO binding at subnanomolar to nanomolar concentrations, suggesting that these analogs bind covalently to MOR. To our knowledge these peptides are the highest affinity peptide-based affinity labels for MOR reported to date.en_US
dc.publisherAmerican Chemical Societyen_US
dc.rightsThis document is the Accepted Manuscript version of a Published Work that appeared in final form in the Journal of Medicinal Chemistry, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see http://dx.doi.org/10.1021/jm9007592.en_US
dc.titleDiscovery of Dermorphin-Based Affinity Labels with Subnanomolar Affinity for Mu Opioid Receptors+en_US
dc.typeArticleen_US
kusw.kuauthorSinha, Bhaswati
kusw.kuauthorAldrich, Jane V.
kusw.kudepartmentMedicinal Chemistryen_US
dc.identifier.doi10.1021/jm9007592en_US
kusw.oaversionScholarly/refereed, author accepted manuscripten_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record